Episodes
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO
Recorded on March 12, 2024
Michael Tees, MD, MPH
Director, Lymphoma Program
Lymphoma Executive Committee Member, Sarah Cannon Research Institute
Associate Member, Colorado Blood Cancer Institute
Denver, CO
Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses
Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an...
Published 04/12/24
Alfred Lee, MD, PhD, Yale University, New Haven, CT
Recorded on February 22, 2024
Alfred Lee, MD, PhD
Professor of Medicine, Yale School of Medicine
Program Director, Hematology and Medical Oncology Fellowship
Chief, Division of Classical Hematology, Yale Cancer Center
Yale University
New Haven, CT
Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in...
Published 03/14/24
Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL
Recorded on December 7, 2023
Meghna Ailawadhi, M.B.B.S., M.D.
Cancer Survivorship Consultant, Assistant Professor of Medicine
Department of Hematology/Oncology
Mayo Clinic
Jacksonville, FL
In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of...
Published 01/30/24
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on December 19, 2023
Lee Greenberger, PhD
Chief Scientific Officer and SVP
The Leukemia & Lymphoma Society
Rye Brook, NY
Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including...
Published 01/10/24
Jeffery Auletta, MD, National Marrow Donor Program® (NMDP)/Be the Match®
Recorded on November 30, 2023
Jeffery Auletta, MD
Senior Vice President, Patient Outcomes and Experience
National Marrow Donor Program® (NMDP)/Be The Match®
Chief Scientific Director
CIBMTR® (Center for International Blood and Marrow Transplant Research®)
National Marrow Donor Program® (NMDP)/Be The Match®
Join us as Dr. Jeffery Auletta from the National Marrow Donor...
Published 12/20/23
Jacqueline Barrientos, MD, MS, Laura Ortiz-Ravick, MA, Kristina Lopez, LCSW
Recorded on November 3, 2023
Jacqueline Barrientos, MD, MS Chief of Hematologic MalignanciesDirector of Oncology ResearchMount Sinai Medical CenterAdjunct Professor of Medicine Zucker School of Medicine at Hofstra/Northwell Miami Beach, FL
Laura Ortiz-Ravick, MADirector, Outreach and Health Promotion The Leukemia & Lymphoma Society Rye Brook,...
Published 12/13/23
Frank Penedo, Ph.D, University of Miami, Miami, FL
Recorded on August 10, 2023
Frank Penedo, Ph.D
Professor, Departments of Psychology and Medicine
Associate Director for Cancer Survivorship and Translational Behavioral Sciences
University of Miami Sylvester Comprehensive Cancer Center
Sylvester DCC Endowed Chair in Cancer Survivorship
University of Miami
Miami, FL
Tune in as we’re joined by Dr. Frank Penedo from the University of Miami for an...
Published 11/21/23
John Salsman, Ph.D, Wake Forest University School of Medicine, Winston-Salem, NC
Recorded on June 22, 2023
John Salsman, Ph.D
Director, Clinical Research in Adolescent and Young Adult (AYA) Oncology
Co-Leader, Cancer Prevention and Control Program at the Atrium Health Wake
Forest Baptist Comprehensive Cancer Center
Professor, Department of Social Sciences and Health Policy at the Wake Forest
University School of Medicine
Winston-Salem, NC...
Published 11/01/23
Tung Wynn, MD, University of Florida, Gainesville, FL and Braulio Hernandez
Recorded on June 10, 2023
Join Dr. Tung Wynn from the University of Florida, and Braulio Hernandez, a childhood cancer advocate and AYA survivor of Hodgkin Lymphoma, as they discuss the unique experiences of adolescents and young adults from active treatment to survivorship. Dr. Wynn and Braulio reflect on the physical and psychosocial long-term and late effects of treatment, strategies to...
Published 08/31/23
Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on April 13, 2023
Chasity Burrows Walters, PhD, RN
Vice President, Educational, Clinical, & Patient Communication
Memorial Sloan Kettering Cancer Center
New York, NY
In this important conversation, Dr. Chasity Burrows Walters from Memorial Sloan Kettering Cancer Center discusses the barriers that persons within the LGBTQI+ community experience in...
Published 06/02/23
Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI
Recorded on January 24, 2023
Ehab Atallah, MD
Professor of Medicine
Associate Director, Cancer Service Line
Section Head, Hematologic Malignancies
Division of Hematology and Oncology
Medical College of Wisconsiny
Milwaukee, WI
In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discuss chronic myeloid leukemia (CML)...
Published 02/21/23
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on December 19, 2022
Lee Greenberger, PhD
Chief Scientific Officer and SVP
The Leukemia & Lymphoma Society
Rye Brook, NY
In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide an update on the information presented at the 64th American Society of Hematology (ASH)...
Published 01/20/23
Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA
Recorded on December 6, 2022
Shayna Sarosiek, MD
Assistant Professor
Harvard Medical School
Dana Farber Cancer Institute
Boston, MA
Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic...
Published 01/04/23
Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX
Recorded on December 16, 2022
Sattva S. Neelapu, MD
Professor and Deputy Chair
Department of Lymphoma and Myeloma
The University of Texas M.D. Anderson Cancer Center
Houston, TX
Chimeric antigen receptor (CAR) T-cell therapy has generated impressive results in hematologic malignancies, with many drugs still in clinical trials. In this episode, Dr. Sattva S. Neelapu from MD Anderson...
Published 12/21/22
Daphne Friedman, MD, Durham VA Health Care System, Durham, NC
Recorded on October 20, 2022
Daphne Friedman, MD
Staff Oncologist, Durham VA Health Care System
Associate Professor, Duke University School of Medicine
Durham, NC
In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discusses the importance of a relationship between the...
Published 11/16/22
Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on October 7, 2022
Eytan M. Stein, MD
Chief, Leukemia Service
Director, Program for Drug Development in Leukemia
Associate Attending Physician
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect on breakthroughs in acute myeloid...
Published 10/27/22
Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on September 30, 2022
Saad Z. Usmani, MD, MBA, FACP
Hematologic Oncologist
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of...
Published 10/14/22
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Recorded on September 6, 2022
Naveen Pemmaraju, MD
Associate Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju...
Published 09/20/22
Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA
Recorded on July 19, 2022
Jason Gotlib, MD
Professor of Medicine in the Division of Hematology
Stanford Cancer Institute
Stanford University School of Medicine
Palo Alto, CA
Mastocytosis is a rare and complex disease. In this special episode, Dr. Jason Gotlib from the Stanford University School of Medicine in Palo Alto, CA, discusses an overview of the disease,...
Published 08/11/22
Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ
Recorded on June 30, 2022
Rafael Fonseca, MD,
Chief Innovation Officer
Getz Family Professor of Cancer
Mayo Clinic
Phoenix, AZ
In this episode, Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, joins Dr. Ken Miller to breakdown the complex and complicated nature of genomics and molecular profiling. He discusses the role of molecular profiling in treating blood cancers, explains how we...
Published 07/20/22
Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC
Recorded on June 9, 2022
Kevin C. Oeffinger, MD, FASCO
Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care
Director, DCI Supportive Care and Survivorship Center
Professor of Medicine, Division of Medical Oncology
Department of Medicine
Duke University Medical Center
Durham, NC
Children diagnosed with cancer are a heterogenous population...
Published 06/23/22
Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on May 20, 2022
Gwen L. Nichols, MD
Chief Medical Officer
The Leukemia & Lymphoma Society
Rye Brook, NY
Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provides free education, support services,...
Published 06/09/22
Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ
Recorded on May 3, 2022
Zalman Suldan, MD, PhD
Attending Physician
Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to appropriate referral to a hematologist-oncologist,...
Published 05/24/22
Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
Recorded on April 8, 2022
Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX
As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxicities reduced. In this episode, Dr. Rayne...
Published 04/26/22